Publication:
Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.

No Thumbnail Available

Date

2019-06-04

Authors

Garcia-Leon, Juan Antonio
Vitorica, Javier
Gutierrez, Antonia

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Most neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust in vitro disease modeling and drug screening platforms for most common neurodegenerative conditions.

Description

MeSH Terms

Animals
CRISPR-Cas Systems
Drug Evaluation, Preclinical
Gene Editing
Humans
Neurodegenerative Diseases
Neurogenesis
Neurons
Pluripotent Stem Cells

DeCS Terms

CIE Terms

Keywords

Alzheimer’s disease, CRISPR-Cas9, Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, disease modeling, drug screening, hiPSCs, human-induced pluripotent stem cells, multiple sclerosis, neurodegenerative disease

Citation